Literature DB >> 16406806

Renewing the T cell repertoire to arrest autoimmune aggression.

Paolo A Muraro1, Daniel C Douek.   

Abstract

There is now evidence that high-dose immune ablation and autologous hematopoietic stem cell transplantation in humans triggers a reconstitution program that leads to the comprehensive renewal of the T cell repertoire. We argue here that several features of this program help to explain how autologous hematopoietic stem cell transplantation can induce long-term clinical remission from organ-specific-, as well as systemic, autoimmune diseases. We propose a model envisioning a coordinated sequence of events, rebuilding an immune system that is competent against infection but that is substantially reconfigured in a way that is less likely to redevelop autoimmunity.

Entities:  

Mesh:

Year:  2006        PMID: 16406806     DOI: 10.1016/j.it.2005.12.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  19 in total

Review 1.  Thymic T-cell development in allogeneic stem cell transplantation.

Authors:  Werner Krenger; Bruce R Blazar; Georg A Holländer
Journal:  Blood       Date:  2011-03-22       Impact factor: 22.113

2.  Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation.

Authors:  Marco Capobianco; Y Motuzova; J Frau; E Cocco; E Mamusa; M G Marrosu; A Bertolotto
Journal:  Neurol Sci       Date:  2011-11-25       Impact factor: 3.307

3.  Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients.

Authors:  L C M Arruda; J C C Lorenzi; A P A Sousa; D L Zanette; P V B Palma; R A Panepucci; D S Brum; A A Barreira; D T Covas; B P Simões; W A Silva; M C Oliveira; K C R Malmegrim
Journal:  Bone Marrow Transplant       Date:  2014-12-08       Impact factor: 5.483

Review 4.  Emerging therapies for multiple sclerosis.

Authors:  Paolo A Muraro; Bibiana Bielekova
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

Review 5.  T cell immune reconstitution following lymphodepletion.

Authors:  Kirsten M Williams; Frances T Hakim; Ronald E Gress
Journal:  Semin Immunol       Date:  2007-11-19       Impact factor: 11.130

Review 6.  Autologous bone marrow transplantation for the treatment of multiple sclerosis.

Authors:  Marta Radaelli; Arianna Merlini; Raffaella Greco; Francesca Sangalli; Giancarlo Comi; Fabio Ciceri; Gianvito Martino
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

Review 7.  The immunopathology of thymic GVHD.

Authors:  Werner Krenger; Georg A Holländer
Journal:  Semin Immunopathol       Date:  2008-10-31       Impact factor: 9.623

8.  T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.

Authors:  Joachim Burman; Moa Fransson; Thomas H Tötterman; Jan Fagius; Sara M Mangsbo; Angelica S I Loskog
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

9.  Autologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosis.

Authors:  Nikolai Pfender; Riccardo Saccardi; Roland Martin
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

10.  T cell repertoire following autologous stem cell transplantation for multiple sclerosis.

Authors:  Paolo A Muraro; Harlan Robins; Sachin Malhotra; Michael Howell; Deborah Phippard; Cindy Desmarais; Alessandra de Paula Alves Sousa; Linda M Griffith; Noha Lim; Richard A Nash; Laurence A Turka
Journal:  J Clin Invest       Date:  2014-02-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.